Pluristem Therapeutics (PSTI) Secures $7.9M Grant for nTRACK Collaborative Project Designed to Study Pluristem’s PLX-PAD Cells
Tweet Send to a Friend
Pluristem Therapeutics Inc. (NASDAQ: PSTI) today announced that a $7.9 million non-dilutive grant from the European Union’s Horizon 2020 program ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
